Perimed AB

Stockholm, Sweden

Perimed AB

Stockholm, Sweden
SEARCH FILTERS
Time filter
Source Type

— Growing demand for blood flow measurement devices in healthcare industry would be the major factor fostering the blood flow measurement devices market. Furthermore, rising prevalence of cardiovascular disease and diabetes coupled with increasing geriatric population, rising demand for minimally invasive surgeries, technological advancements in blood flow measurement devices, wide usage of these devices in various clinical applications, influx of VC funding, huge R&D investments by market players and increasing demand for technically advanced non-invasive devices are the factors fuelling market growth. However, stringent compliance requirements, high pricing of the devices, growing alternative methods to treat cardiovascular diseases and implementation of the Patient Protection and Affordable Healthcare Act, 2010 are limiting the market growth. Ultrasonic doppler segment is projected to witness substantial breakthrough advancements over the coming decade and is expected to provide lucrative avenues of growth. In Non-invasive applications, cardiovascular disease segment accounted for the major share whereas, Coronary Artery Bypass Grafting (CABG) devices dominated the invasive applications segment. North American region dominated the global blood flow measurement devices market with maximum revenue share due to rising prevalence of cardiovascular diseases & hypertension, increasing geriatric population, continues R&D activities for advanced products and favourable reimbursement scenario. Asia Pacific is expected to witness fastest growth on account of rapidly increasing demand for advanced healthcare technologies, increasing prevalence of cardiovascular diseases and diabetes in countries such as India and China. Some of the key players in global market include Ace Medicals, Adinstruments, ATYS Medical, Biomedix Inc, Biopac Systems Inc., Compumedics Limited, Cook Medical, Inc., Deltex Medical Group PLC, Getinge Group, Medistim ASA, Medtronics, Moor Instruments Ltd., Perimed AB, Sonotec Ultraschallsensorik Halle GmbH and Transonic Systems, Inc. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit: http://www.strategymrc.com For more information, please visit http://www.strategymrc.com/


Karlsson H.,Linköping University | Fredriksson I.,Linköping University | Fredriksson I.,Perimed AB | Larsson M.,Linköping University | Stromberg T.,Linköping University
Optics Express | Year: 2012

A spectroscopic probe with multiple detecting fibers was used for quantifying absorption and scattering in liquid optical phantoms. The phantoms were mixtures of Intralipid and red and blue food dyes. Intensity calibration for the detecting fibers was undertaken using either a microsphere suspension (absolute calibration) or a uniform detector illumination (relative calibration between detectors). Two different scattering phase functions were used in an inverse Monte Carlo algorithm. Data were evaluated for residual spectra (systematic deviations and magnitude) and accuracy in estimation of scattering and absorption. Spectral fitting was improved by allowing for a 10% intensity relaxation in the optimization algorithm. For a multi-detector setup, non-systematic residual spectrum was only found using the more complex Gegenbauer-kernel phase function. However, the choice of phase function did not influence the accuracy in the estimation of absorption and scattering. Similar estimation accuracy as in the multi-detector setup was also obtained using either two relative calibrated detectors or one absolute calibrated detector at a fiber separation of 0.46 mm. © 2012 Optical Society of America.


Fredriksson I.,Linköping University | Fredriksson I.,Perimed AB | Burdakov O.,Linköping University | Larsson M.,Linköping University | Stromberg T.,Linköping University
Journal of Biomedical Optics | Year: 2013

The tissue fraction of red blood cells (RBCs) and their oxygenation and speed-resolved perfusion are estimated in absolute units by combining diffuse reflectance spectroscopy (DRS) and laser Doppler flowmetry (LDF). The DRS spectra (450 to 850 nm) are assessed at two source-detector separations (0.4 and 1.2 mm), allowing for a relative calibration routine, whereas LDF spectra are assessed at 1.2mmin the same fiber-optic probe. Data are analyzed using nonlinear optimization in an inverse Monte Carlo technique by applying an adaptive multilayered tissue model based on geometrical, scattering, and absorbing properties, as well as RBC flow-speed information. Simulations of 250 tissue-like models including up to 2000 individual blood vessels were used to evaluate the method. The absolute root mean square (RMS) deviation between estimated and true oxygenation was 4.1 percentage units, whereas the relative RMS deviations for the RBC tissue fraction and perfusion were 19% and 23%, respectively. Examples of in vivo measurements on forearm and foot during common provocations are presented. The method offers several advantages such as simultaneous quantification of RBC tissue fraction and oxygenation and perfusion from the same, predictable, sampling volume. The perfusion estimate is speed resolved, absolute (% RBC × mm/s), and more accurate due to the combination with DRS. © 2013 The Authors.


Karlsson H.,Linköping University | Pettersson A.,Perimed AB | Larsson M.,Linköping University | Stromberg T.,Linköping University
Progress in Biomedical Optics and Imaging - Proceedings of SPIE | Year: 2011

Model based analysis of calibrated diffuse reflectance spectroscopy can be used for determining oxygenation and concentration of skin chromophores. This study aimed at assessing the effect of including melanin in addition to hemoglobin (Hb) as chromophores and compensating for inhomogeneously distributed blood (vessel packaging), in a single-layer skin model. Spectra from four humans were collected during different provocations using a twochannel fiber optic probe with source-detector separations 0.4 and 1.2 mm. Absolute calibrated spectra using data from either a single distance or both distances were analyzed using inverse Monte Carlo for light transport and Levenberg-Marquardt for non-linear fitting. The model fitting was excellent using a single distance. However, the estimated model failed to explain spectra from the other distance. The two-distance model did not fit the data well at either distance. Model fitting was significantly improved including melanin and vessel packaging. The most prominent effect when fitting data from the larger separation compared to the smaller separation was a different light scattering decay with wavelength, while the tissue fraction of Hb and saturation were similar. For modeling spectra at both distances, we propose using either a multi-layer skin model or a more advanced model for the scattering phase function. © 2011 SPIE.


Stromberg T.,Linköping University | Karlsson H.,Linköping University | Fredriksson I.,Linköping University | Fredriksson I.,Perimed AB | And 2 more authors.
Journal of Biomedical Optics | Year: 2014

Microvascular assessment would benefit from co-registration of blood flow and hemoglobin oxygenation dynamics during stimulus response tests. We used a fiber-optic probe for simultaneous recording of white light diffuse reflectance (DRS; 475850 nm) and laser Doppler flowmetry (LDF; 780 nm) spectra at two sourcedetector distances (0.4 and 1.2 mm). An inverse Monte Carlo algorithm, based on a multiparameter three-layer adaptive skin model, was used for analyzing DRS data. LDF spectra were conventionally processed for perfusion. The system was evaluated on volar forearm recordings of 33 healthy subjects during a 5-min systolic occlusion protocol. The calibration scheme and the optimal adaptive skin model fitted DRS spectra at both distances within 10%. During occlusion, perfusion decreased within 5 s while oxygenation decreased slowly (mean time constant 61 s; dissociation of oxygen from hemoglobin). After occlusion release, perfusion and oxygenation increased within 3 s (inflow of oxygenized blood). The increased perfusion was due to increased blood tissue fraction and speed. The supranormal hemoglobin oxygenation indicates a blood flow in excess of metabolic demands. In conclusion, by integrating DRS and LDF in a fiber-optic probe, a powerful tool for assessment of blood flow and oxygenation in the same microvascular bed has been presented. © The Authors.


Fredriksson I.,Linköping University | Fredriksson I.,Perimed AB | Larsson M.,Linköping University | Stromberg T.,Linköping University
Journal of Biomedical Optics | Year: 2012

Model based data analysis of diffuse reflectance spectroscopy data enables the estimation of optical and structural tissue parameters. The aim of this study was to present an inverse Monte Carlo method based on spectra from two source-detector distances (0.4 and 1.2 mm), using a multilayered tissue model. The tissue model variables include geometrical properties, light scattering properties, tissue chromophores such as melanin and hemoglobin, oxygen saturation and average vessel diameter. The method utilizes a small set of presimulated Monte Carlo data for combinations of different levels of epidermal thickness and tissue scattering. The path length distributions in the different layers are stored and the effect of the other parameters is added in the post-processing. The accuracy of the method was evaluated using Monte Carlo simulations of tissue-like models containing discrete blood vessels, evaluating blood tissue fraction and oxygenation. It was also compared to a homogeneous model. The multilayer model performed better than the homogeneous model and all tissue parameters significantly improved spectral fitting. Recorded in vivo spectra were fitted well at both distances, which we previously found was not possible with a homogeneous model. No absolute intensity calibration is needed and the algorithm is fast enough for realtime processing. © 2012 Society of Photo-Optical Instrumentation Engineers (SPIE).


MarketStudyReport.com adds “Global Transcutaneous Oxygen Monitor Market by Manufacturers, Regions, Type and Application, Forecast to 2021” new report to its research database. The report spread across 113 pages with table and figures in it. Transcutaneous Oxygen Monitor is the device used for transcutaneous oximetry (TcPO2 or TCOM), which is a local, non-invasive measurement reflecting the amount of O2 that has diffused from the capillaries through the epidermis. This measurement provides information regarding the supply and delivery of oxygen to the underlying micro vascular circulation. It can be used for adults in wound evaluation, hyperbaric therapy, plastic surgery, amputation level determination, and peripheral vascular disease assessment, including the status of limb revascularization procedures Browse full table of contents and data tables at https://www.marketstudyreport.com/reports/global-transcutaneous-oxygen-monitor-market-by-manufacturers-regions-type-and-application-forecast-to-2021-2/ Scope of the Report This report focuses on the Transcutaneous Oxygen Monitor in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Radiometer Medicap Humares Sentec Radiometer Perimed AB Philips Humares Medicap Humares Perimed AB Philips Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Latin America, Middle East and Africa Market Segment by Type, covers Wound-healing Monitor Baby Monitor Other Market Segment by Applications, can be divided into Hospitals Clinics There are 13 Chapters to deeply display the global Transcutaneous Oxygen Monitor market. Chapter 1, to describe Transcutaneous Oxygen Monitor Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Transcutaneous Oxygen Monitor , with sales, revenue, and price of Transcutaneous Oxygen Monitor , in 2015 and 2016; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016; Chapter 4, to show the global market by regions, with sales, revenue and market share of Transcutaneous Oxygen Monitor , for each region, from 2011 to 2016; Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016; Chapter 11, Transcutaneous Oxygen Monitor market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021; Chapter 12 and 13, to describe Transcutaneous Oxygen Monitor sales channel, distributors, traders, dealers, appendix and data source. To receive personalized assistance write to us @ [email protected] with the report title in the subject line along with your questions or call us at +1 866-764-2150


News Article | November 3, 2016
Site: www.newsmaker.com.au

Transcutaneous Oxygen Monitor is the device used for transcutaneous oximetry (TcPO2 or TCOM), which is a local, non-invasive measurement reflecting the amount of O2 that has diffused from the capillaries through the epidermis. This measurement provides information regarding the supply and delivery of oxygen to the underlying micro vascular circulation. It can be used for adults in wound evaluation, hyperbaric therapy, plastic surgery, amputation level determination, and peripheral vascular disease assessment, including the status of limb revascularization procedures Scope of the Report  This report focuses on the Transcutaneous Oxygen Monitor in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Regions, regional analysis covers  North America (USA, Canada and Mexico)  Europe (Germany, France, UK, Russia and Italy)  Asia-Pacific (China, Japan, Korea, India and Southeast Asia)  Latin America, Middle East and Africa Market Segment by Applications, can be divided into  Hospitals  Clinics There are 13 Chapters to deeply display the global Transcutaneous Oxygen Monitor market. Chapter 2, to analyze the top manufacturers of Transcutaneous Oxygen Monitor , with sales, revenue, and price of Transcutaneous Oxygen Monitor , in 2015 and 2016; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016; Chapter 4, to show the global market by regions, with sales, revenue and market share of Transcutaneous Oxygen Monitor , for each region, from 2011 to 2016; Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions; Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016; Chapter 11, Transcutaneous Oxygen Monitor market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021; Chapter 12 and 13, to describe Transcutaneous Oxygen Monitor sales channel, distributors, traders, dealers, appendix and data source. 1 Market Overview  1.1 Transcutaneous Oxygen Monitor Introduction  1.2 Market Analysis by Type  1.2.1 Wound-healing Monitor  1.2.2 Baby Monitor  1.2.3 Other  1.3 Market Analysis by Applications  1.3.1 Hospitals  1.3.2 Clinics  1.4 Market Analysis by Regions  1.4.1 North America (USA, Canada and Mexico)  1.4.1.1 USA  1.4.1.2 Canada  1.4.1.3 Mexico  1.4.2 Europe (Germany, France, UK, Russia and Italy)  1.4.2.1 Germany  1.4.2.2 France  1.4.2.3 UK  1.4.2.4 Russia  1.4.2.5 Italy  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)  1.4.3.1 China  1.4.3.2 Japan  1.4.3.3 Korea  1.4.3.4 India  1.4.3.5 Southeast Asia  1.4.4 Latin America, Middle East and Africa  1.4.4.1 Brazil  1.4.4.2 Egypt  1.4.4.3 Saudi Arabia  1.4.4.4 South Africa  1.4.4.5 Nigeria  1.5 Market Dynamics  1.5.1 Market Opportunities  1.5.2 Market Risk  1.5.3 Market Driving Force  2 Manufacturers Profiles  2.1 Radiometer  2.1.1 Business Overview  2.1.2 Transcutaneous Oxygen Monitor Type and Applications  2.1.2.1 Type 1  2.1.2.2 Type 2  2.1.3 Radiometer Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.2 Medicap  2.2.1 Business Overview  2.2.2 Transcutaneous Oxygen Monitor Type and Applications  2.2.2.1 Type 1  2.2.2.2 Type 2  2.2.3 Medicap Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.3 Humares  2.3.1 Business Overview  2.3.2 Transcutaneous Oxygen Monitor Type and Applications  2.3.2.1 Type 1  2.3.2.2 Type 2  2.3.3 Humares Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.4 Sentec  2.4.1 Business Overview  2.4.2 Transcutaneous Oxygen Monitor Type and Applications  2.4.2.1 Type 1  2.4.2.2 Type 2  2.4.3 Sentec Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.5 Radiometer  2.5.1 Business Overview  2.5.2 Transcutaneous Oxygen Monitor Type and Applications  2.5.2.1 Type 1  2.5.2.2 Type 2  2.5.3 Radiometer Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.6 Perimed AB  2.6.1 Business Overview  2.6.2 Transcutaneous Oxygen Monitor Type and Applications  2.6.2.1 Type 1  2.6.2.2 Type 2  2.6.3 Perimed AB Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.7 Philips  2.7.1 Business Overview  2.7.2 Transcutaneous Oxygen Monitor Type and Applications  2.7.2.1 Type 1  2.7.2.2 Type 2  2.7.3 Philips Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.8 Humares  2.8.1 Business Overview  2.8.2 Transcutaneous Oxygen Monitor Type and Applications  2.8.2.1 Type 1  2.8.2.2 Type 2  2.8.3 Humares Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.9 Medicap  2.9.1 Business Overview  2.9.2 Transcutaneous Oxygen Monitor Type and Applications  2.9.2.1 Type 1  2.9.2.2 Type 2  2.9.3 Medicap Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.10 Humares  2.10.1 Business Overview  2.10.2 Transcutaneous Oxygen Monitor Type and Applications  2.10.2.1 Type 1  2.10.2.2 Type 2  2.10.3 Humares Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.11 Perimed AB  2.11.1 Business Overview  2.11.2 Transcutaneous Oxygen Monitor Type and Applications  2.11.2.1 Type 1  2.11.2.2 Type 2  2.11.3 Perimed AB Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  2.12 Philips  2.12.1 Business Overview  2.12.2 Transcutaneous Oxygen Monitor Type and Applications  2.12.2.1 Type 1  2.12.2.2 Type 2  2.12.3 Philips Transcutaneous Oxygen Monitor Sales, Price, Revenue, Gross Margin and Market Share  3 Global Transcutaneous Oxygen Monitor Market Competition, by Manufacturer  3.1 Global Transcutaneous Oxygen Monitor Sales and Market Share by Manufacturer  3.2 Global Transcutaneous Oxygen Monitor Revenue and Market Share by Manufacturer  3.3 Market Concentration Rate  3.3.1 Top 3 Transcutaneous Oxygen Monitor Manufacturer Market Share  3.3.2 Top 6 Transcutaneous Oxygen Monitor Manufacturer Market Share  3.4 Market Competition Trend  4 Global Transcutaneous Oxygen Monitor Market Analysis by Regions  4.1 Global Transcutaneous Oxygen Monitor Sales, Revenue and Market Share by Regions  4.1.1 Global Transcutaneous Oxygen Monitor Sales by Regions (2011-2016)  4.1.2 Global Transcutaneous Oxygen Monitor Revenue by Regions (2011-2016)  4.2 North America Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  4.3 Europe Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  4.4 Asia-Pacific Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  4.5 Latin America Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  4.6 Middle East and Africa Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  5 North America Transcutaneous Oxygen Monitor by Countries  5.1 North America Transcutaneous Oxygen Monitor Sales, Revenue and Market Share by Countries  5.1.1 North America Transcutaneous Oxygen Monitor Sales by Countries (2011-2016)  5.1.2 North America Transcutaneous Oxygen Monitor Revenue by Countries (2011-2016)  5.2 USA Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  5.3 Canada Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  5.4 Mexico Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  6 Europe Transcutaneous Oxygen Monitor by Countries  6.1 Europe Transcutaneous Oxygen Monitor Sales, Revenue and Market Share by Countries  6.1.1 Europe Transcutaneous Oxygen Monitor Sales by Countries (2011-2016)  6.1.2 Europe Transcutaneous Oxygen Monitor Revenue by Countries (2011-2016)  6.2 Germany Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  6.3 UK Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  6.4 France Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  6.5 Russia Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  6.6 Italy Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  7 Asia-Pacific Transcutaneous Oxygen Monitor by Countries  7.1 Asia-Pacific Transcutaneous Oxygen Monitor Sales, Revenue and Market Share by Countries  7.1.1 Asia-Pacific Transcutaneous Oxygen Monitor Sales by Countries (2011-2016)  7.1.2 Asia-Pacific Transcutaneous Oxygen Monitor Revenue by Countries (2011-2016)  7.2 China Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  7.3 Japan Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  7.4 Korea Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  7.5 India Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  7.6 Southeast Asia Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  8 Latin America, Middle East and Africa Transcutaneous Oxygen Monitor by Countries  8.1 Latin America, Middle East and Africa Transcutaneous Oxygen Monitor Sales, Revenue and Market Share by Countries  8.1.1 Latin America, Middle East and Africa Transcutaneous Oxygen Monitor Sales by Countries (2011-2016)  8.1.2 Latin America, Middle East and Africa Transcutaneous Oxygen Monitor Revenue by Countries (2011-2016)  8.2 Brazil Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  8.3 Saudi Arabia Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  8.4 Egypt Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  8.5 Nigeria Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  8.6 South Africa Transcutaneous Oxygen Monitor Sales and Growth (2011-2016)  9 Transcutaneous Oxygen Monitor Market Segment by Type  9.1 Global Transcutaneous Oxygen Monitor Sales, Revenue and Market Share by Type (2011-2016)  9.1.1 Global Transcutaneous Oxygen Monitor Sales and Market Share by Type (2011-2016)  9.1.2 Global Transcutaneous Oxygen Monitor Revenue and Market Share by Type (2011-2016)  9.2 Wound-healing Monitor Sales Growth and Price  9.2.1 Global Wound-healing Monitor Sales Growth (2011-2016)  9.2.2 Global Wound-healing Monitor Price (2011-2016)  9.3 Baby Monitor Sales Growth and Price  9.3.1 Global Baby Monitor Sales Growth (2011-2016)  9.3.2 Global Baby Monitor Price (2011-2016)  9.4 Other Sales Growth and Price  9.4.1 Global Other Sales Growth (2011-2016)  9.4.2 Global Other Price (2011-2016)  10 Transcutaneous Oxygen Monitor Market Segment by Application  10.1 Global Transcutaneous Oxygen Monitor Sales Market Share by Application (2011-2016)  10.2 Sales Growth (2011-2016)  10.3 Hospitals Sales Growth (2011-2016)  10.4 Clinics Sales Growth (2011-2016)  10.5 Sales Growth (2011-2016)  11 Transcutaneous Oxygen Monitor Market Forecast (2016-2021)  11.1 Global Transcutaneous Oxygen Monitor Sales, Revenue and Growth Rate (2016-2021)  11.2 Transcutaneous Oxygen Monitor Market Forecast by Regions (2016-2021)  11.3 Transcutaneous Oxygen Monitor Market Forecast by Type (2016-2021)  11.4 Transcutaneous Oxygen Monitor Market Forecast by Application (2016-2021)  12 Sales Channel, Distributors, Traders and Dealers  12.1 Sales Channel  12.1.1 Direct Marketing  12.1.2 Indirect Marketing  12.1.3 Marketing Channel Future Trend  12.2 Distributors, Traders and Dealers  13 Appendix  13.1 Methodology  13.2 Analyst Introduction  13.3 Data SourceList of Tables and Figures


Zion Research has published a new report titled “Blood Flow Measurement Devices Market (Laser Doppler Blood Flowmeters, Electromagnetic Blood Flowmeters and Ultrasonic Doppler Blood Flowmeters) for Diabetes, Peripheral Vascular Diseases, Dermatology, Gastroenterology, Tumor Monitoring and Other Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”. According to the report, global demand for the blood flow measurement devices market was valued at around USD 354.2million in 2015 and is expected to generate revenue of around USD 554.3 million by end of 2021, growing at a CAGR of around 7.8% between 2016 and 2021. Blood flow measurement devices are typically used for measurement of blood flow. This rate is calculated based on the amount of blood passing through a cross section of a blood vessel per unit time. It is used to obtainvascular assessment data by the blood flow measurement devices which help physicians to maintain the equilibrium between demand and supply of tissue oxygen of patients.Blood flow measurement devices play a very vital role in detection of number of clinical vascular conditions such as peripheral vascular diseases such as diabetic macroandmicro vascular complications and arterial occlusion.Some of the different types of blood flow measurement devices include laser doppler blood flowmeters, electromagnetic blood flowmeters and ultrasonic doppler blood flowmeters. Global blood flow measurement devices market is primarily driven by rising number of target disease such as peripheral artery diseases, diabetes, etc. across the globe. Other major driving factors aregrowing geriatric population coupled along with increasing demand for non-invasive surgeries and technologically advanced devices. However, high price of these devices and stringent regulatory policies are the major restraints that may limit the growth of the market. Nonethelessincreasing clinical applications coupled along with emerging markets across the globearelikely to disclose the new avenues for blood flow measurement devices market in the near future. The blood flow measurement devices market is segmented on the basis of different products including laser doppler blood flowmeters, electromagnetic blood flowmeters, and ultrasonic doppler blood flowmeters. In 2015, ultrasonic doppler blood flow meters was the largest segment in blood flow measurement devices market and accounted for largest share of the total market. Additionally, it is expected to continue its dominance in global market over the forecast period. Diabetes, peripheral vascular diseases, dermatology, gastroenterology, tumor monitoring and others are the key application of the global blood flow measurement devices market. The peripheral vascular diseasesegment dominated the market in terms of revenue and is expected to show moderategrowth within the forecast period. Know more before buying this report @  https://www.zionmarketresearch.com/inquiry/blood-flow-measurement-devices-market North America, Europe, Asia-Pacific, Latin America and Middle East & Africa are key regional segments of global blood flow measurement devices market. North America is anticipated to remain the leading region over the forecast period in 2015. Demand for blood flow measurement devices was highest in Asia-Pacific. Hence, Asia Pacific is expected to be the fastest growing region in blood flow measurement devices market during the forecast period. Moreover, Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come. Some of the key players in the blood flow measurement devices market include Cook Medical Inc., Atys Medical, Deltex Medical, ArjoHuntleigh Inc.,Elcat GmBH, Compumedics Ltd.,Moor Instruments Ltd., GF Health Products, Inc., and Transonic Systems Inc.,.Medistim ASA, and Perimed AB among others. This report segments the global blood flow measurement devices market as follows:


Roustit M.,French Institute of Health and Medical Research | Maggi F.,Perimed AB | Isnard S.,French Institute of Health and Medical Research | Hellmann M.,French Institute of Health and Medical Research | And 2 more authors.
Microvascular Research | Year: 2010

Objective: In the present study we aimed to assess the reproducibility of skin microvascular reactivity while fast cooling locally with a custom-designed laser-Doppler flowmetry (LDF) probe. Methods: Twenty-two healthy volunteers underwent local 15 °C cooling on the forearm during 5 (protocol 1, n = 12) or 30 min (protocol 2, n = 10). Skin blood flow was concomitantly assessed using LDF. Measurements were repeated after 30 min (protocol 1) or 7 days (protocols 1 and 2). Data were expressed as cutaneous vascular conductance (CVC) and percentage of baseline (%BL). Within subject coefficients of variation (CV) and intra-class correlation coefficients (ICC) were calculated. Results: Immediate reproducibility of the 5-min cooling was very good, either expressed as CVC or %BL (CV were 8% and 18%; ICC were 0.85 and 0.78, respectively). However, the 30-min cooling was the most reproducible at 1 week, either as CVC or %BL (CV were 26% and 23%; ICC were 0.86 and 0.75, respectively). Local cooling was well tolerated by all volunteers. Conclusions: We propose in the present work a reproducible 30-min LDF cooling test. Such a tool could be of great interest to assess microvascular reactivity to local cooling in diseases such as Raynaud's syndrome, and to further evaluate drugs for such diseases. © 2009 Elsevier Inc. All rights reserved.

Loading Perimed AB collaborators
Loading Perimed AB collaborators